Concepedia

Lina Davies Forsman

LD

Statistics

Publications

28

Citations

1.2K

H-Index

19

Active since

2014

Affiliations

Karolinska Institutet(Current)

Karolinska University Hospital

Public Health Agency of Sweden

Fudan University

The University of Sydney

Lina Davies Forsman is an author at Karolinska Institutet specializing in pharmacology, tuberculosis drug resistance, and tuberculosis pharmacotherapy.

ORCID

Publications per year

2014–2024

28

Publications

28

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Borisov Se, Keertan Dheda, Martin Enwerem et al. · European Respiratory Journal · 2017 · 302 citations · Full text

, , +16

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Borisov Se, Edvardas Danila, Andrei Maryandyshev et al. · European Respiratory Journal · 2019 · 177 citations · Full text

, , +17

Clinical standards for the dosing and management of TB drugs

Jan‐Willem C. Alffenaar, Sophie L. Stocker, Lina Davies Forsman et al. · The International Journal of Tuberculosis and Lung Disease · 2022 · 62 citations · Full text

, , +17

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

Onno W. Akkerman, Alena Aleksa, Jan‐Willem C. Alffenaar et al. · International Journal of Infectious Diseases · 2019 · 56 citations · Full text

, , +16

Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment Response

Xubin Zheng, Ziwei Bao, Lina Davies Forsman et al. · Clinical Infectious Diseases · 2020 · 52 citations

, , +14

1–5 of 28